| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | — | — |
| Cost of Revenue | $1K | — | — |
| Gross Profit | $884 | — | — |
| R&D Expense | $208K | -41.1% | +2870.0% |
| SG&A Expense | $513K | +29.6% | -18.7% |
| Operating Income | -$1.1M | -43.2% | -432.2% |
| Income Tax | $1K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $35K | — | — |
| Current Assets | $2.4M | +142.9% | +3788.0% |
| Total Assets | $2.4M | +142.9% | -63.9% |
| Current Liabilities | $13.9M | +31.3% | +110.9% |
| Total Liabilities | $13.9M | +30.8% | +111.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.0M | — | — |
| Financing Cash Flow | $5.9M | — | — |
| +0.0% |
| Net Income | -$1.9M | +6.6% | -244.6% |
| EPS (Basic) | -$0.04 | +99.9% | -300.0% |
| EPS (Diluted) | -$0.04 | +99.9% | -300.0% |
| -$11.5M |
| -19.2% |
| -76.1% |